|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/04 | |
| A61K 31/4025 | |||
| A61P 7/12 |
| (11) | Number of the document | 3044222 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14780663.2 |
| Date of filing the European patent application | 2014-09-10 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/054888 |
| Date | 2014-09-10 |
| (87) | Number | WO 2015/038571 |
| Date | 2015-03-19 |
| (30) | Number | Date | Country code |
| 201361877101 P | 2013-09-12 | US | |
| 201314133297 | 2013-12-18 | US |
| (72) |
GONG, Yuchuan, US
ZHANG, Geoff, G., US
|
| (73) |
Abbvie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
| (54) | ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES |
| ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES |